Cite

HARVARD Citation

    Nilsson, M. et al. (2020). Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19. Statistics in biopharmaceutical research. pp. 498-505. [Online]. 
  
Back to record